BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 27794494)

  • 21. miRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy.
    Gao S; Tian H; Guo Y; Li Y; Guo Z; Zhu X; Chen X
    Acta Biomater; 2015 Oct; 25():184-93. PubMed ID: 26169933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D-SP5 Peptide-Modified Highly Branched Polyethylenimine for Gene Therapy of Gastric Adenocarcinoma.
    Li X; Xie Z; Xie C; Lu W; Gao C; Ren H; Ying M; Wei X; Gao J; Su B; Ren Y; Liu M
    Bioconjug Chem; 2015 Aug; 26(8):1494-503. PubMed ID: 26052814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models.
    Mizuno M; Ryuke Y; Yoshida J
    Cancer Gene Ther; 2002 Oct; 9(10):825-9. PubMed ID: 12224023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.
    Rainov NG; Fels C; Droege JW; Schäfer C; Kramm CM; Chou TC
    Cancer Gene Ther; 2001 Sep; 8(9):662-8. PubMed ID: 11593335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted gene delivery to glioblastoma using a C-end rule RGERPPR peptide-functionalised polyethylenimine complex.
    Wang J; Lei Y; Xie C; Lu W; Yan Z; Gao J; Xie Z; Zhang X; Liu M
    Int J Pharm; 2013 Dec; 458(1):48-56. PubMed ID: 24144951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Suicide gene therapy for glioma using HSV-tk/GCV system].
    Xu L; Ge K; Zheng Z
    Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):353-7. PubMed ID: 10920915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma.
    Ryu CH; Park KY; Kim SM; Jeong CH; Woo JS; Hou Y; Jeun SS
    Biochem Biophys Res Commun; 2012 May; 421(3):585-90. PubMed ID: 22525671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular imaging and treatment of malignant gliomas following adenoviral transfer of the herpes simplex virus-thymidine kinase gene and the somatostatin receptor subtype 2 gene.
    Verwijnen SM; Sillevis Smith PA; Hoeben RC; Rabelink MJ; Wiebe L; Curiel DT; Hemminki A; Krenning EP; de Jong M
    Cancer Biother Radiopharm; 2004 Feb; 19(1):111-20. PubMed ID: 15068619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A leptin derived 30-amino-acid peptide modified pegylated poly-L-lysine dendrigraft for brain targeted gene delivery.
    Liu Y; Li J; Shao K; Huang R; Ye L; Lou J; Jiang C
    Biomaterials; 2010 Jul; 31(19):5246-57. PubMed ID: 20382424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic RGD-poly(ethylene glycol)-polyethyleneimine is more suitable for glioblastoma targeting gene transfer in vivo.
    Zhan C; Qian J; Feng L; Zhong G; Zhu J; Lu W
    J Drug Target; 2011 Aug; 19(7):573-81. PubMed ID: 21166603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo.
    Zhan C; Wei X; Qian J; Feng L; Zhu J; Lu W
    J Control Release; 2012 Jun; 160(3):630-6. PubMed ID: 22410115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.
    Rainov NG
    Hum Gene Ther; 2000 Nov; 11(17):2389-401. PubMed ID: 11096443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copolymer of poly(ethylene glycol) and poly(L-lysine) grafting polyethylenimine through a reducible disulfide linkage for siRNA delivery.
    Li J; Cheng D; Yin T; Chen W; Lin Y; Chen J; Li R; Shuai X
    Nanoscale; 2014; 6(3):1732-40. PubMed ID: 24346086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of Flt3L for glioma therapeutics.
    Puntel M; Muhammad AK; Candolfi M; Salem A; Yagiz K; Farrokhi C; Kroeger KM; Xiong W; Curtin JF; Liu C; Bondale NS; Lerner J; Pechnick RN; Palmer D; Ng P; Lowenstein PR; Castro MG
    J Virol; 2010 Jun; 84(12):6007-17. PubMed ID: 20375153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Herpes simplex virus type 1 thymidine kinase-armed bovine herpesvirus type 4-based vector displays enhanced oncolytic properties in immunocompetent orthotopic syngenic mouse and rat glioma models.
    Redaelli M; Franceschi V; Capocefalo A; D'Avella D; Denaro L; Cavirani S; Mucignat-Caretta C; Donofrio G
    Neuro Oncol; 2012 Mar; 14(3):288-301. PubMed ID: 22228853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arginine-rich polyplexes for gene delivery to neuronal cells.
    Morris VB; Labhasetwar V
    Biomaterials; 2015 Aug; 60():151-60. PubMed ID: 26000961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyethylenimine-grafted copolymer of poly(l-lysine) and poly(ethylene glycol) for gene delivery.
    Dai J; Zou S; Pei Y; Cheng D; Ai H; Shuai X
    Biomaterials; 2011 Feb; 32(6):1694-705. PubMed ID: 21093048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD).
    Sheikh MA; Malik YS; Xing Z; Guo Z; Tian H; Zhu X; Chen X
    Acta Biomater; 2017 May; 54():58-68. PubMed ID: 28025049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.